Boston Scientific Increase (Decrease) in Other Operating Assets increased by 251.6% to $109.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 41.6%, from $77.00M to $109.00M.
An increase represents a use of cash, while a decrease represents a source of cash from working capital adjustments.
Reflects the net change in miscellaneous operating assets not captured in specific line items like receivables or invent...
Standard working capital line item found in most corporate cash flow statements.
operating_increase_decrease_in_other_operating_assets| Q2 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $72.00M | $140.00M | $104.00M | $54.00M | $41.00M | $14.00M | -$12.00M | -$53.00M | $55.00M | $71.00M | $17.00M | $77.00M | $31.00M | $109.00M |
| QoQ Change | — | +94.4% | -25.7% | -48.1% | -24.1% | -65.9% | -185.7% | -341.7% | +203.8% | +29.1% | -76.1% | +352.9% | -59.7% | +251.6% |
| YoY Change | — | — | +44.4% | — | -70.7% | -86.5% | -122.2% | — | +34.1% | +407.1% | +132.1% | +40.0% | -56.3% | +41.6% |